A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score

Fox, 2007, Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006, JAMA, 297, 1892, 10.1001/jama.297.17.1892 Amsterdam, 2014, AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 64, e139, 10.1016/j.jacc.2014.09.017 Roffi, 2016, Eur Heart J, 37, 267, 10.1093/eurheartj/ehv320 Tanguay, 2013, Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy, Can J Cardiol, 29, 1334, 10.1016/j.cjca.2013.07.001 Eagle, 2004, A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry, JAMA, 291, 2727, 10.1001/jama.291.22.2727 Fox, 2006, Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE), BMJ, 333, 1091, 10.1136/bmj.38985.646481.55 Granger, 2003, Predictors of hospital mortality in the global registry of acute coronary events, Arch Intern Med, 63, 2345, 10.1001/archinte.163.19.2345 Fox, 2014, Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score, BMJ Open, 4, e004425, 10.1136/bmjopen-2013-004425 Antman, 2000, The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making, JAMA, 284, 835, 10.1001/jama.284.7.835 Lindahl, 2000, Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease, N Engl J Med, 343, 1139, 10.1056/NEJM200010193431602 Liuzzo, 1994, The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina, N Engl J Med, 331, 417, 10.1056/NEJM199408183310701 James, 2003, Circulation, 108, 275, 10.1161/01.CIR.0000079170.10579.DC Giraldez, 2013, Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome, Am Heart J, 165, 918, 10.1016/j.ahj.2013.01.005 Sabatine, 2012, Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease, Circulation, 125, 233, 10.1161/CIRCULATIONAHA.111.063842 Zethelius, 2008, Use of multiple biomarkers to improve the prediction of death from cardiovascular causes, N Engl J Med, 358, 2107, 10.1056/NEJMoa0707064 Scirica, 2011, Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial, Eur Heart J, 32, 697, 10.1093/eurheartj/ehq468 Morrow, 2007, National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes, Circulation, 115, e356, 10.1161/CIRCULATIONAHA.107.182882 Yusuf, 2001, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med, 345, 494, 10.1056/NEJMoa010746 Sullivan, 2004, Presentation of multivariate data for clinical use: the Framingham study risk score functions, Stat Med, 23, 1631, 10.1002/sim.1742 Pencina, 2011, Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers, Stat Med, 30, 11, 10.1002/sim.4085 Austin, 2004, Bootstrapping methods for developing predictive models, Am Stat, 58, 131, 10.1198/0003130043277 Mehta, 2009, Early versus delayed invasive intervention in acute coronary syndromes, N Engl J Med, 360, 2165, 10.1056/NEJMoa0807986 Eggers, 2009, Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome, J Am Coll Cardiol, 54, 357, 10.1016/j.jacc.2009.03.056 Wallentin, 2009, Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 361, 1045, 10.1056/NEJMoa0904327 Wiviott, 2007, Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 357, 2001, 10.1056/NEJMoa0706482